A case of neurocognitive deficit strongly related to dasatinib therapy

by Kamal Chamoun, Emma Rabinovich, Linda Baer, Philip Fastenau, Marcos de Lima
Published 2020-01-01

Socioeconomic Factors and Survival of Multiple Myeloma Patients

by Kamal Chamoun, Amin Firoozmand, Paolo Caimi, Pingfu Fu, Shufen Cao, Folashade Otegbeye, Leland Metheny, Seema Patel, Stanton L. Gerson, Kirsten Boughan, Marcos De Lima, Ehsan Malek
Published 2021-02-01

Early detection of transformation to BPDCN in a patient with MDS

by Kamal Chamoun, Sanam Loghavi, Naveen Pemmaraju, Marina Konopleva, Michael Kroll, Madeleine Nguyen-Cao, Marisa Hornbaker, Courtney D. DiNardo, Tapan Kadia, Jeffrey Jorgensen, Michael Andreeff, Shimin Hu, Christopher B. Benton
Published 2018-10-01

Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience

by Kamal Chamoun, Hagop Kantarjian, Rami Atallah, Graciela Nogueras Gonzalez, Ghayas C. Issa, Mary Beth Rios, Guillermo Garcia-Manero, Gautam Borthakur, Farhad Ravandi, Nitin Jain, Naval Daver, Marina Konopleva, Courtney D. DiNardo, Tapan Kadia, Naveen Pemmaraju, Elias Jabbour, Jorge Cortes
Published 2019-01-01

Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study

by Marie Maerevoet, Josee M. Zijlstra, George Follows, Rene-Olivier Casasnovas, J. S. P. Vermaat, Nagesh Kalakonda, Andre Goy, Sylvain Choquet, Eric Van Den Neste, Brian Hill, Catherine Thieblemont, Federica Cavallo, Fatima De la Cruz, John Kuruvilla, Nada Hamad, Ulrich Jaeger, Paolo Caimi, Ronit Gurion, Krzysztof Warzocha, Sameer Bakhshi, Juan-Manuel Sancho, Michael Schuster, Miklos Egyed, Fritz Offner, Theodoros P. Vassilakopoulos, Priyanka Samal, Matthew Ku, Xiwen Ma, Kelly Corona, Kamal Chamoun, Jatin Shah, Sharon Shacham, Michael G. Kauffman, Miguel Canales
Published 2021-07-01